Session » Abstracts: Vasculitis – Non-ANCA-Associated & Related Disorders (0502–0507)
- 3:30PM-3:45PM
-
Abstract Number: 0502
Global Transcriptomic Profiling Identifies Differential Gene Expression Signatures Between Inflammatory and Non-inflammatory Aortic Aneurysms
- 3:45PM-4:00PM
-
Abstract Number: 0503
18F-fluorodeoxyglucose Positron Emission Tomography as a Predictor of Angiographic Progression of Disease in Large-vessel Vasculitis
- 4:00PM-4:15PM
-
Abstract Number: 0504
Longitudinal Patterns of Vascular Inflammation in Large-vessel Vasculitis
- 4:15PM-4:30PM
-
Abstract Number: 0505
Risk of Venous and Arterial Thromboembolism in Patients with Giant Cell Arteritis And/or Polymyalgia Rheumatica: A Veterans Health Administration Population-Based Study in the United States
- 4:30PM-4:45PM
-
Abstract Number: 0506
Transcriptomic Changes Induced by Mavrilimumab versus Tocilizumab in ex-vivo Cultured Arteries from Patients with Giant-cell Arteritis
- 4:45PM-5:00PM
-
Abstract Number: 0507
Tocilizumab in Patients with New Onset Polymyalgia Rheumatica (PMR-SPARE) – a Phase 2/3 Randomized Controlled Trial